Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gallstone-dissolving agents.

C J Peine1

  • 1University of Minnesota and Hennepin County Medical Center, Minneapolis.

Gastroenterology Clinics of North America
|September 1, 1992
PubMed
Summary

Nonsurgical gallstone treatments like ursodiol, contact dissolution, and extracorporeal shock wave lithotripsy (ESWL) offer effective options. Proper patient selection and ongoing research are key to optimizing these gallstone therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.

Hepatology (Baltimore, Md.)·2000
Same author

Biliary-shunt fistula following transjugular intrahepatic portosystemic shunt placement.

Gastroenterology·1996
Same author

The non-bleeding visible vessel versus the sentinel clot: natural history and risk of rebleeding.

Gastrointestinal endoscopy·1993
Same author

Objective evaluation of endoscopy skills during training.

Annals of internal medicine·1993
Same author

Safety of same-day sequential extracorporeal shock wave lithotripsy and dissolution of gallstones by methyl tert-butyl ether in dogs.

Mayo Clinic proceedings·1990
Same author

Extracorporeal shock-wave lithotripsy and methyl tert-butyl ether for partially calcified gallstones.

Gastroenterology·1989

Area of Science:

  • Gastroenterology
  • Hepatology
  • Minimally Invasive Surgery

Background:

  • New therapies for gallstones often generate initial optimism, which is later tempered by clinical experience and the realization of limitations.
  • The management of gallstones has evolved, with various nonsurgical modalities experiencing different adoption rates.

Purpose of the Study:

  • To provide perspective on the appropriate use of current nonsurgical gallstone management modalities.
  • To highlight the efficacy and limitations of specific treatments, including ursodiol, contact dissolution, and ESWL.

Main Methods:

  • Review of clinical experience and therapeutic outcomes for nonsurgical gallstone treatments.
  • Analysis of patient selection criteria and technical considerations for ursodiol, MTBE contact dissolution, and ESWL combined with oral bile acids.

Main Results:

  • Ursodiol can achieve partial or complete dissolution in up to 75% of non-obese patients with small, radiolucent stones, cost-effectively and with minimal side effects.
  • Contact dissolution using MTBE is safe and effective but requires careful stone characterization to avoid pigmented or calcified stones.
  • ESWL combined with oral bile acids is effective when limited to patients with suitable cholesterol stone burdens and continued until fragments are significantly reduced.

Conclusions:

  • Each nonsurgical gallstone treatment modality has a defined role based on patient and stone characteristics.
  • Continued research into new solvents, technologies, and recurrence prevention will further refine the field of nonsurgical gallstone management.

Related Experiment Videos